Aarti Drugs

350.80
-15.05
(-4.11%)
Market Cap
3,201.75 Cr
EPS
18.56
PE Ratio
22.02
Dividend Yield
0.27 %
Industry
Healthcare
52 Week High
635.00
52 Week Low
312.00
PB Ratio
2.63
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
-6.83 %
Net Income Growth
3.12 %
Cash Flow Change
169.22 %
ROE
-4.01 %
ROCE
-6.00 %
EBITDA Margin (Avg.)
11.75 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
283
273
265
314
292
316
291
299
258
319
336
332
375
348
380
464
406
478
474
459
546
578
533
503
582
580
642
697
622
688
665
743
662
642
608
621
557
600
569
Expenses
240
230
226
269
244
265
247
253
223
267
282
274
322
300
328
403
351
409
410
378
411
462
425
421
500
506
545
608
555
614
593
649
577
565
536
534
490
531
495
EBITDA
44
42
40
45
48
51
43
46
36
53
54
57
54
47
52
61
55
69
64
81
135
117
108
82
81
74
97
89
67
74
72
94
85
77
72
87
66
69
74
Operating Profit %
15 %
16 %
15 %
14 %
16 %
16 %
15 %
16 %
14 %
16 %
16 %
17 %
14 %
14 %
14 %
12 %
13 %
14 %
13 %
16 %
25 %
20 %
20 %
16 %
14 %
13 %
14 %
12 %
11 %
11 %
11 %
13 %
13 %
12 %
12 %
14 %
12 %
11 %
11 %
Depreciation
9
9
9
9
10
10
10
9
10
10
10
10
10
11
11
11
12
12
12
13
12
13
13
12
12
13
13
13
13
13
13
13
13
13
13
14
13
14
14
Interest
10
11
11
12
10
9
9
9
9
8
9
9
9
10
11
10
9
9
8
8
7
7
5
4
4
5
5
6
7
9
9
9
9
8
8
9
9
9
9
Profit Before Tax
25
23
23
25
29
33
24
31
17
35
35
38
34
27
31
40
34
48
43
61
116
97
90
65
65
56
79
71
48
53
50
73
64
56
52
64
44
46
51
Tax
8
7
6
6
9
11
6
9
5
11
12
14
10
9
10
12
11
16
15
2
31
22
22
14
16
14
20
15
13
14
13
17
16
17
15
17
11
11
14
Net Profit
17
16
17
19
20
22
18
22
11
24
23
24
23
18
21
27
23
32
28
59
85
75
68
52
49
43
58
55
35
39
37
56
48
40
37
47
33
35
37
EPS in ₹
7.18
6.49
7.03
7.68
8.21
9.11
7.56
8.70
4.77
9.89
9.78
9.97
9.82
7.65
8.86
12.06
9.56
13.87
11.92
25.26
9.17
8.08
7.30
5.54
5.25
4.60
6.29
5.97
3.76
4.18
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
Fixed Assets
449
493
581
602
625
644
665
690
676
811
Current Assets
526
565
571
737
784
900
1,057
1,393
1,492
1,321
Capital Work in Progress
16
34
14
28
33
12
19
77
210
261
Investments
0
0
12
11
12
13
17
20
19
20
Other Assets
537
575
584
748
785
907
1,064
1,422
1,516
1,340
Total Liabilities
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
Current Liabilities
483
501
494
622
591
623
595
940
950
796
Non Current Liabilities
211
244
297
312
321
301
257
232
279
355
Total Equity
308
357
400
455
543
653
913
1,036
1,193
1,282
Reserve & Surplus
284
333
376
432
520
629
820
944
1,100
1,190
Share Capital
24
24
24
24
24
23
93
93
93
92

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-0
0
1
2
2
13
-14
-1
Investing Activities
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
Operating Activities
105
133
175
70
143
251
155
70
133
359
Financing Activities
2
-33
-68
4
-80
-215
-81
92
17
-136

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
55.64 %
55.38 %
55.48 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.33 %
2.10 %
2.56 %
2.96 %
2.50 %
2.28 %
2.25 %
DIIs
1.59 %
1.97 %
2.09 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
7.84 %
8.77 %
9.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.86 %
32.32 %
32.68 %
32.85 %
32.02 %
32.16 %
26.66 %
25.98 %
25.72 %
25.34 %
24.65 %
25.84 %
25.11 %
24.75 %
24.80 %
24.32 %
23.51 %
Others
6.36 %
5.57 %
5.11 %
4.89 %
5.46 %
5.10 %
10.41 %
10.46 %
10.61 %
11.25 %
9.14 %
9.33 %
9.20 %
9.27 %
9.21 %
9.24 %
9.06 %
No of Share Holders
1,73,704
1,77,992
1,83,344
1,95,469
1,89,607
1,86,674
1,80,303
1,73,283
1,69,090
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 1 2 2.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.79 0.63 0.8 0.29 0.58 0.3 0.23 0.29 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsApr 02, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsApr 02, 2025
Closure of Trading WindowMar 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")Mar 07, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") - Action Taken Or Order PassedMar 06, 2025
Announcement Under Regulation 30 Of Listing Regulations - ESG RatingMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFAFeb 14, 2025
Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. AuthorityFeb 07, 2025
Disclosure Under Regulation 30 Of Listing Regulations-Feb 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 29, 2025
Integrated Filing (Financial)Jan 29, 2025
Record Date For Interim DividendJan 29, 2025
Corporate Action-Board approves DividendJan 29, 2025
Board Meeting Outcome for Financial Results And Interim DividendJan 29, 2025
Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim DividendJan 29, 2025
Disclosure Under Regulation 30 Of Listing RegulationsJan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 23, 2025
Board Meeting Intimation for Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend If Any.Jan 22, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Closure of Trading WindowDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 22, 2024
Restoration Of Manufacturing Process Of Particular Product At T-150 UnitNov 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 06, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 02, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 02, 2024
Announcement under Regulation 30 (LODR)-Credit RatingOct 30, 2024

Technical Indicators

RSI(14)
Neutral
48.80
ATR(14)
Volatile
14.25
STOCH(9,6)
Overbought
85.45
STOCH RSI(14)
Overbought
87.34
MACD(12,26)
Bullish
3.69
ADX(14)
Weak Trend
14.75
UO(9)
Bearish
48.88
ROC(12)
Uptrend And Accelerating
5.38
WillR(14)
Neutral
-37.06